Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: A critical role for nitric oxide

Journal of Leukocyte Biology

Volumn 73, Issue 5, 2003, Pages 621-629

  Nishioka, Yasuhiko ^a   Wen, Hua ^a   Mitani, Kayo ^a   Robbins, Paul D ^b   Lotze, Michael T ^b   Sone, Saburo ^a   Tahara, Hideaki ^c  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

IFN ; L NMMA; MLR

Indexed keywords

CD34 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 12; N(G) METHYLARGININE; NITRIC OXIDE; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE DONOR;

ALLOIMMUNITY; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; DOSE RESPONSE; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; IN VITRO STUDY; MIXED LYMPHOCYTE REACTION; MONOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; ANIMAL; ANTIGEN PRESENTATION; BIOSYNTHESIS; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; COMPARATIVE STUDY; DRUG EFFECT; FEMALE; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; MASTOCYTOMA; METABOLISM; MIXED LYMPHOCYTE CULTURE; PATHOLOGY; PHYSIOLOGY; SPECIES DIFFERENCE; T CELL LYMPHOMA;

ANIMALIA; MURINAE;

ANIMALS; ANTIGEN PRESENTATION; BONE MARROW CELLS; DENDRITIC CELLS; FEMALE; HUMANS; IMMUNE TOLERANCE; IMMUNITY, CELLULAR; INTERFERON TYPE II; INTERLEUKIN-12; LYMPHOCYTE CULTURE TEST, MIXED; LYMPHOMA, T-CELL; MASTOCYTOMA; MICE; MICE, INBRED C57BL; NITRIC OXIDE; NITRIC OXIDE DONORS; OMEGA-N-METHYLARGININE; S-NITROSO-N-ACETYLPENICILLAMINE; SPECIES SPECIFICITY; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED;

EID: 0038500950     PISSN: 07415400     EISSN: None     Source Type: Journal    
DOI: 10.1189/jlb.0402205     Document Type: Article

References (50)

1. Lamont, A. G., Adorini, L. (1996) IL-12: a key cytokine in immune regulation. Immunol. Today 17, 214-217.
2. Trinchieri, G. (1998) Interleukin-12: a cytokine at the interface of inflammation and immunity. Adv. Immunol. 70, 83-243.
3. Voest, E. E., Kenyon, B. M., O'Reilly, M. S., Truilt, G., D'Amato, R. J., Folkman, J. (1996) Inhibition of angiogenesis in vivo by interleukin 12. J. Natl. Cancer Inst. 87, 581-586.
4. Sgadari, C., Angiolillo, A. L., Tosato, G. (1996) Inhibition of angiogenesis by interleukin 12 is mediated by the interferon-inducible protein 10. Blood 87, 3877-3882.
5. Brunda, M. J., Luistro, L., Warrier, R. R., Wright, R. B., Hubbard, B. R., Murphy, M., Wolf, S. F., Gately, M. K. (1993) Antitumor and antimelastatic activity of interleukin 12 against murine tumors. J. Exp. Med. 178, 1223-1230.
6. Nastala, C. L., Edington, H. D., McKinney, T. G., Tahara, H., Nalesnik, M. A., Brunda, M. J., Gately, M. K., Wolf, S. F., Schreiber, R. D., Storkus, W. J., Lotze, M. T. (1994) Recombinant IL-12 administration induces tumor regression in association with IFN-γ production. J. Immunol. 153, 1697-1706.
7. Tahara, H., Zitvogel, L., Storkus, W. J., Zeb, III, H. J., McKinney, T. G., Schreiber, R. D., Gubler, U., Robbins, P. D., Lotze, M. T. (1995) Effective eradication of established murine tumors with IL-12 gene therapy using a polycistronic retroviral vector. J. Immunol. 154, 6466-6474.
8. Martinotti, A., Stoppacciaro, A., Vagliani, M., Melani, C., Spreafico, F., Wysocka, M., Parmiani, G., Trinchieri, G., Colombo, M. P. (1995) CDIT cells inhibit in vivo the CD8-mediated immune response against murine colon carcinoma cells transduced with interleukin-12 gene. Eur. J. Immunol. 25, 137-146.
9. Noguchi, Y., Richards, E. C., Chen, Y-T., Old, L. J. (1995) Influence of interleukin 12 on p53 peptide vaccination against established Meth A sarcoma. Proc. Natl. Acad. Sci. USA 92, 2219-2223.
10. Orange, J. S., Wolf, S. F., Biron, C. A. (1994) Effects of IL-12 on the response and susceptibility to experimental viral infections. J. Immunol. 152, 1253-1264.
11. Piccotti, J. R., Chan, S. Y., Goodman, R. E., Magram, J., Eichwald, E. J., Bishop, D. K. (1996) IL-12 antagonism induces T helper 2 responses, yet exacerbates cardiac allograft rejection. Evidence against a dominant protective role for T helper 2 cytokines in alloimmunity. J. Immunol. 157, 1951-1957.
12. Kurzawa, H., Wysocka, M., Aruga, E., Chang, A. E., Trinchieri, G., Lee, W. M. F. (1998) Recombinant interleukin 12 enhances cellular immune responses to vaccination only after a period of suppression. Cancer Res. 58, 491-499.
13. Koblish, H. K., Hunter, C. A., Wysocka, M., Trinchieri, G., Lee, W. M. F. (1998) Immune suppression by recombinant interleukin (rIL)-12 involves interferon γ induction of nitric oxide synthase 2 (iNOS) activity: inhibitors of NO generation reveal the extent of rIL-12 vaccine adjuvant effect. J. Exp. Med. 188, 1603-1610.
14. Steinman, R. M. (1991) The dendritic cell system and its role in immunogenicity. Annu. Rev. Immunol. 9, 271-296.
15. Bonham, C. A., Lu, L., Li, Y., Hoffman, R. A., Simmons, R. L., Thomson, A. W. (1996) Nitric oxide production by mouse bone marrow-derived dendritic cells. Transplantation 62, 1871-1877.
16. Inaba, K., Inaba, M., Naito, M., Steinman, R. M. (1993) Dendritic cell progenitors phagocytose particulates, including Bacillus Calmette-Guerin organisms, and sensitize mice to mycobacterial antigens in vivo. J. Exp. Med. 178, 479-488.
17. Mayordomo, J. I., Zorina, T., Storkus, W. J., Zitvogel, L., Celluzzi, C., Falo, L. D., Melief, C. J., Ildslad, S. T., Martin Kast, W., Deleo, A. B., Lotze, M. T. (1995) Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumor immunity. Nat. Med. 1, 1297-1302.
18. Zitvogel, L., Mayordomo, J. I., Tjandrawan, T., Deleo, A. B., Clarke, M. R., Lotze, M. T., Storkus, W. J. (1996) Therapy of murine tumors with tumor peptide-pulsed dendritic cells: dependence on T cells, B7 costimulation, and T helper cell I-associated cytokines. J. Exp. Med. 183, 87-97.
19. Nishioka, Y., Hirao, M., Robbins, P. D., Lotze, M. T., Tahara, H. (1999) Induction of systemic and therapeutic antitumor immunity using intratumoral injection of dendritic cells genetically modified to constitutively express interleukin-12. Cancer Res. 59, 4035-4041.
20. Bahnson, A. B., Dunigan, J. T., Baysal, B. E., Mohney, T., Atchison, R. W., Ningaonkar, M. T., Ball, E. D., Barranger, J. A. (1995) Centrifugal enhancement of retroviral mediated gene transfer. J. Virol. Methods 54, 131-143.
21. Henderson, R. A., Nimgaonkar, M. T., Watkins, S. C., Robbins, P. D., Ball, E. D., Finn, O. J. (1996) Human dendritic cells genetically engineered to express high levels of the human epithelial tumor antigen mucin (MUC-1). Cancer Res. 56, 3763-3770.
22. Reeves, M. E., Royal, R. E., Lam, J. S., Rosenberg, S. A., Hwu, P. (1996) Retroviral transduction of human dendritic cells with a tumor-associated antigen gene. Cancer. Res. 56, 5672-5677.
23. Nishimura, N., Nishioka, Y., Shinohara, T., Tani, K., Sone, S. (2000) Down-regulation by a new anti-inflammatory compound, FR1676537, of differentiation and maturation of human monocytes and bone marrow CD34+ cells to dendritic cells. Int. J. Immunopharmacol. 22, 501-514.
24. Parajuli, P., Nishioka, Y., Nishimura, N., Singh, S. M., Hanibuchi, M., Nokihara, H., Yanagawa, H., Sone, S. (1999) Cytolysis of human dendritic cells by antologous lymphokine-activated killer cells: participation of both T cells and NK cells in the killing. J. Leukoc. Biol. 65, 764-770.
25. Nishimura, N., Nishioka, Y., Shinohara, T., Sone, S. (2001) Enhanced efficiency by centrifugal manipulation of adenovirus-mediated interleukin 12 transduction into human monocyte-derived dendritic cells. Hum. Gene Ther. 12, 333-346.
26. + blood dendritic cells enhance NK cell-mediated cytotoxicity. Eur. J. Immunol. 31, 2633-2641.
27. Tüting, T., Wilson, C. C., Martin, D. M., Kasanton, Y. L., Rowles, J., Ma, D. I., Slingluff Jr., C. L., Wagner, S. N., van der Bruggen, P., Baar, J., Lotze, M. T., Storkus, W. J. (1998) Autologous human monocyte-derived dendritic cells genetically modified to express melanoma antigens elicit primary cytotoxic T cell responses in vitro: enhancement by cotransfection of genes encoding the Th1-biasing cytokines IL-12 and IFN-γ. J. Immunol. 1160, 1139-1147.
28. 15N]nitrate in biological fluids. Anal. Biochem. 126, 131-138.
29. Bonham, C. A., Lu, L., Li, Y., Hoffman, R. A., Simmons, R. L., Thompson, A. W. (1996) Nitric oxide production by mouse bone marrow-derived dendritic cells. Transplantation 62, 1871-1877.
30. Osaki, T., Péron, J-M., Cai, Q., Okamura, H., Robbins, P. D., Kurimoto, M., Lotze, M. T., Tahara, H. (1998) IFN-γ-inducing factor/IL-18 administration mediates IFN-γ- and IL-12-independent antitumor effects. J. Immunol. 160, 1742-1749.
31. Specht, J. M., Wang, G., Do, M. T., Lam, J. S., Royal, R. E., Reeves, M. E., Rosenberg, S. A., Hwu, P. (1997) Dendritic cells retrovirally transduced with a model antigen gene are therapeutically effective against established pulmonary metastases. J. Exp. Med. 186, 1213-1221.
32. Magram, J., Connaughton, S. E., Warrier, R. R., Carvajal, D. M., Wu, C-Y., Ferrante, J., Stewart, C., Sarmiento, U., Faherty, D. A., Gately, M. K. (1996) IL-12-deficient mice are defective in IFN production and type 1 cytokine responses. Immunity 4, 471-481.
33. Piccotti, J. R., Li, K., Chan, S. Y., Ferrante, J., Magram, J., Eichwald, E. J., Bishop, D. K. (1998) Antigen-reactive TH1 development in IL-12-deficient mice. J. Immunol. 160, 1132-1138.
34. Chouaib, S., Chehimi, J., Bani, L., Genetet, N., Tursz, T., Gay, F., Truchieri, G., Manri-Chouaib, F. (1994) Interleukin 12 induces the differentiation of major histocompatibility complex class I-primed cytotoxic T-lymphocyte precursors into allospecific cytotoxic effectors. Proc. Natl. Acad. Sci. USA. 91, 12659-12663.
35. Albina, J. E., Abate, J. A., Henry Jr., W. L. (1991) Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation: role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147, 144-148.
36. Hoffman, R. A., Langrehr, J. M., Billiar, T. R., Curran, R. D., Simmons, R. L. (1990) Alloantigen-induced activation of rat splenocytes is regulated by the oxidative metabolism of L-arginine. J. Immunol. 145, 2220-2226.
37. Denham, S., Rowland, I. J. (1992) Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide. Clin. Exp. Immunol. 87, 157-162.
38. Lagrehr, J. M., Dull, K. E., Ochoa, J.B., Billiar, T. R., Ildstad, S. T., Schrant, W. H., Simmons, R. L., Hoffman, R. A. (1992) Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 53, 632-640.
39. Andrews, K. J., Ribas, A., Butterfield, L. H., Volmer, C. M., Eilber, F. C., Disselle, V. J., Nelson, S. D., Shintaku, P., Mekhoubad, S., Nakayama, T., Taniguchi, M., Glaspy, J. A., McBride, W. H., Economon, J. S. (2000) Adenovirus-interleukin-12-mediated tumor regression in a murine hepatocellular carcinoma model is not dependent on CDI-restricted natural killer T cells. Cancer Res. 60, 6457-6464.
40. Boggio, K., Nicoletti, G., Di Carlo, E., Cavallo, F., Landuzzi, L., Melani, C., Giovarelli, M., Rossi, I., Nanni, P., De Giovanni, C., Bouchard, P., Wolf, S., Modesti, A., Musiani, P., Lollini, P. L., Colombo, M. P., Forni, G. (1998) Interleukin 12-mediated prevention of Spontaneous mammary adenocarcinoma in two lines of Her-2/neu transgenic mice. J. Exp. Med. 188, 589-596.
41. Horvath-Arcidiacona, J. A., Mostowski, H. S., Boom, E. T. (1996) IL-12 administered in vivo to young and aged mice. Discrepancy between the effects on tumor growth in vivo and cytotoxic T lymphocyte generation ex vivo: dependence on IFN-γ. Int. Immunol. 8, 661-673.
42. Lu, L., Bonham, C. A., Chambers, F. G., Watkins, S. C., Hoffman, R. A., Simmons, R. L., Thomson, A. W. (1996) Induction of nitric oxide synthase in mouse dendritic cells by IFN-γ, endotoxin, and interaction with allogeneic T cells. Nitric oxide production is associated with dendritic cells apoptosis. J. Immunol. 157, 3577-3586.
43. Albina, J. E., Abale, J. A., Henry Jr., W. L. (1991) Nitric oxide production is required for murine resident peritoneal macrophages to suppress mitogen-stimulated T cell proliferation. Role of IFN-γ in the induction of the nitric oxide-synthesizing pathway. J. Immunol. 147, 144-148.
44. Denham, S., Rowland, I. J. (1992) Inhibition of the reactive proliferation of lymphocytes by activated macrophages: the role of nitric oxide. Clin. Exp. Immunol. 87, 157-162.
45. Langrehr, J. M., Dull, K. E., Ochoa, J. B., Billiar, T. R., Ildslad, S. T., Schraut, W. H., Simmons, R. L., Hoffman, R. A. (1992) Evidence that nitric oxide production by in vivo allosensitized cells inhibits the development of allospecific CTL. Transplantation 53, 632-640.
46. Piccotti, J. R., Li, K., Chan, S. Y., Eichwald, E. J., Bishop, D. K. (1999) Interleukin-12 (IL-12)-driven alloimmune responses in vitro and in vivo. Requirement for β1 subunit of the IL-12 receptor. Transplantation 67, 1453-1460.
47. Bloom, E. T., Horvath, J. A. (1994) Cellular and molecular mechanisms of the IL-12-induced increase in allospecific murine cytolytic T cell activity: implications for the age-related decline in CTL. J. Immunol. 152, 4242-4254.
48. Steinman, R. M., Cohn, Z. A. (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J. Exp. Med. 137, 1142-1162.
49. Fallarino, F., Uyttenhove, C., Boon, T., Gajewski, T. F. (1999) Improved efficacy of dendritic cell vaccines and successful immunization with tumor antigen peptide-pulsed peripheral blood mononuclear cells by coadministration of recombinant murine interleukin-12. Int. J. Cancer 80, 324-333.
50. Dalton, D. K., Pitts-Meek, S., Keshav, S., Figari, I. S., Bradley, A., Stewart, T. A. (1993) Multiple defects of immune cell function in mice with disrupted interferon-γ genes. Science 259, 1739-1742.